日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

[Development of destructive thyroiditis and diabetes mellitus after three injections of pembrolizumab for skin melanoma]

[接受三次帕博利珠单抗治疗皮肤黑色素瘤后出现破坏性甲状腺炎和糖尿病]

Glibka, A A; Mel Nichenko, G A; Mikhina, M S; Mazurina, N V; Kharkevich, G Yu

[Clinical practice guidelines for acute and chronic thyroiditis (excluding autoimmune thyroiditis)]

[急性及慢性甲状腺炎(不包括自身免疫性甲状腺炎)临床实践指南]

Troshina, E A; Panfilova, E A; Mikhina, M S; Kim, I V; Senyushkina, E S; Glibka, A A; Shifman, B M; Larina, A A; Sheremeta, M S; Degtyarev, M V; Rumyanstsev, P O; Kuznetzov, N S; Melnichenko, G A; Dedov, I I